News from merck kgaa, darmstadt, germany A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 22, 2019, 08:00 ET Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva, Switzerland. The panel entitled, ...


Nov 19, 2018, 08:00 ET Syntropy to Unlock the Value of Scientific Data in Fight to End Cancer

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and software company Palantir Technologies, today announced their intent to form a joint venture under the brand name...


Nov 06, 2018, 09:00 ET Embracing Carers™ expands support for caregivers worldwide

Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business in the U.S. and Canada as EMD Serono, today announced the continued expansion of Embracing Carers™. The global...


Jun 04, 2018, 10:38 ET Merck KGaA, Darmstadt, Germany Presents Updated Clinical Results for Bifunctional Immunotherapy M7824 at ASCO 2018

ASCO Abstract # M7824 (TGF-ß trap/anti-PD-L1): 3007, 9017, 2566, TPS3130; Tepotinib (c-Met kinase inhibitor): 9082, 9016; M2698 (dual p70S6k/Akt inhibitor): 2584; M6620 (ATR inhibitor): 2549; M3814...


Feb 15, 2018, 08:33 ET Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

Not intended for UK-based media DARMSTADT, Germany and NEW YORK, Feb. 15, 2018 /CNW/ - Merck and Pfizer Inc. (NYSE: PFE) today announced results from the Phase III JAVELIN Lung 200 trial comparing...


Dec 05, 2017, 08:41 ET Merck KGaA, Darmstadt, Germany Announces FDA 510(k) Clearance of Partner Genea Biomedx's Fertility Benchtop Incubator Geri™

Expanded Fertility Technology portfolio highlights Merck KGaA, Darmstadt, Germany's commitment to improve fertility treatment outcomes for patients U.S. commercial availability expected in first half ...


Nov 28, 2017, 08:42 ET Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer

Not intended for UK-based media Pivotal Phase III Javelin trial investigating avelumab as third-line treatment for patients with unresectable, recurrent or metastatic gastric cancer did not meet its...


Sep 18, 2017, 02:15 ET Merck KGaA, Darmstadt, Germany Announces Recipients of the Grant for Growth Innovation 2017

The presentation of the grants coincides with the 10th International Meeting of Pediatric Endocrinology The awards program supports advancement in the field of growth and growth disorders DARMSTADT,...


Feb 08, 2017, 09:13 ET North American Businesses of Merck KGaA, Darmstadt, Germany Certified as 2017 Top Employer

Merck KGaA, Darmstadt, Germany, a leading science and technology company which operates as EMD Serono, MilliporeSigma and EMD Performance Materials in the United States and Canada, today announced...


Nov 01, 2016, 12:22 ET Merck KGaA, Darmstadt, Germany Partners with American Cancer Society to Address Cancer in Women

Cancer deaths in women are expected to increase to 5.5 million by 2030 DARMSTADT, Germany, Nov. 1, 2016 /CNW/ - Merck KGaA, Darmstadt, Germany, a leading science and technology company, and the...


Sep 22, 2016, 14:55 ET Merck KGaA, Darmstadt, Germany and the Royal Health Awareness Society Partner to Advance Women's Health in Jordan

New partnership under Healthy Women, Healthy Economies initiative facilitates women to overcome health barriers to economic participation DARMSTADT, Germany, Sept. 22, 2016 /CNW/ - Merck KGaA,...


Sep 12, 2016, 02:15 ET Merck KGaA, Darmstadt, Germany Announces Recipients of the Grant for Growth Innovation 2016

The presentation of the grants coincides with the 55th European Society for Paediatric Endocrinology (ESPE) Meeting The awards support innovative projects for the advancement of science and medical...


Jul 19, 2016, 08:00 ET MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts

MilliporeSigma today announced plans to build a new campus in Burlington, Massachusetts that will serve as a major hub for the North American life science business of Merck KGaA, Darmstadt, Germany....


Dec 07, 2015, 04:06 ET Merck KGaA, Darmstadt, Germany, Decides Not to Pursue Evofosfamide Further in Soft Tissue Sarcoma and Pancreatic Cancer

Despite signs of activity in locally advanced and metastatic pancreatic cancer, two Phase III studies did not meet pre-specified primary endpoints Merck KGaA, Darmstadt, Germany, focus efforts on...